KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...
SCHAUMBURG, Ill., July 25 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company, today announced that it haslaunched amiodarone HCl injection, USP, a class III antiarrhythmic ...
The DFT is defined as the lowest delivered energy that will convert VF to a supraventricular rhythm. An increase in DFT may lead to failure of device therapy, and as a result may have severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback